Adding $100 to These 5 Stocks Would Be a Genius Move Right Now

10:21am, Wednesday, 09'th Nov 2022 The Motley Fool
You don't need a large pile of cash to begin building wealth on Wall Street.
You don't need a large pile of cash to begin building wealth on Wall Street.

Why Teva Stock Stumbled Again on Friday

10:03pm, Friday, 04'th Nov 2022 The Motley Fool
A degree of uncertainty about the company's leadership compounded some rather discouraging recent developments.

Why Teva Stock Stumbled Again on Friday

06:03pm, Friday, 04'th Nov 2022
A degree of uncertainty about the company's leadership compounded some rather discouraging recent developments.
TEVA reports dismal Q3 results, missing estimates for both earnings and sales. It slightly lowers its sales expectations for 2022 while keeping the adjusted earnings per share guidance intact.

Why Teva Stock Sank On Thursday

09:57pm, Thursday, 03'rd Nov 2022 The Motley Fool
There were two major developments with the company, both of which involved piles of money.

Why Teva Stock Sank On Thursday

05:57pm, Thursday, 03'rd Nov 2022
There were two major developments with the company, both of which involved piles of money.

Teva Pharmaceutical Industries (TEVA) Q3 2022 Earnings Call Transcript

04:30pm, Thursday, 03'rd Nov 2022 The Motley Fool
TEVA earnings call for the period ending September 30, 2022.
Teva Pharmaceutical Industries Limited (NYSE:TEVA ) Q3 2022 Earnings Conference Call November 3, 2022 8:00 AM ET Company Participants Ran Meir - Senior Vice President, Head of Investor Relations Kare
The Israeli company will shell out as much as $4.2 billion nationwide as part of a tentative deal.
The New York Attorney General's office announced it has secured $523 million from Teva Pharmaceuticals and affiliates for its role in the opioid crisis, effectively marking the end of the state's liti
Yahoo Finance's Anjalee Khemlani joins the Live show to discuss the FDA's warning of an Adderall shortage after Teva experiences a manufacturing delay.
The European Commission's antitrust accusation against Teva is poorly timed. Teva's selling momentum could continue from here.

Why Teva Stock Shot More Than 3% Higher Today

09:55pm, Friday, 30'th Sep 2022 The Motley Fool
The generic drugs specialist settled one of a number of state lawsuits over its business practices.

Why Teva Stock Shot More Than 3% Higher Today

05:55pm, Friday, 30'th Sep 2022
The generic drugs specialist settled one of a number of state lawsuits over its business practices.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE